[HTML][HTML] Therapeutic options against the new coronavirus: updated clinical and laboratory evidences
ACL Fernandes, AJM Vale, FP Guzen… - Frontiers in …, 2020 - frontiersin.org
The pandemic caused by the new coronavirus (SARS-Cov-2) has encouraged numerous in
vitro studies and clinical trials around the world, with research groups testing existing drugs …
vitro studies and clinical trials around the world, with research groups testing existing drugs …
[HTML][HTML] SARS-CoV-2 therapeutics: how far do we stand from a remedy?
The SARS-CoV-2 has affected millions worldwide and has posed an immediate need for
effective pharmacological interventions. Ever since the outbreak was declared, the medical …
effective pharmacological interventions. Ever since the outbreak was declared, the medical …
[HTML][HTML] Current status of COVID-19 treatment: An opinion review
The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
has garnered the attention of scientists worldwide in the search for an effective treatment …
has garnered the attention of scientists worldwide in the search for an effective treatment …
Treatment of SARS-CoV-2: How far have we reached?
The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently
affecting more than 200 countries and territories worldwide. It has been declared as …
affecting more than 200 countries and territories worldwide. It has been declared as …
Advances in the possible treatment of COVID-19: A review.
P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
[HTML][HTML] Treatment and research lines for the patient with COVID-19. What do we have and where are we going?
C Gotera - International braz j urol, 2020 - SciELO Brasil
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health …
syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health …
[HTML][HTML] Natural history of COVID-19 and current knowledge on treatment therapeutic options
WG Dos Santos - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Despite intense research there is currently no effective vaccine available against the new
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …
[HTML][HTML] Therapeutic options for COVID-19: a review
R Pujari, MV Thommana, BR Mercedes, A Serwat - Cureus, 2020 - ncbi.nlm.nih.gov
An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …
[HTML][HTML] COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs
A Bartoli, F Gabrielli, T Alicandro, F Nascimbeni… - Internal and emergency …, 2021 - Springer
Since its outbreak in China in December 2019 a novel Coronavirus, named SARS-CoV-2,
has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 …
has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 …